Insmed Incorporated
INSM
$132.17
$3.853.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.86% | -35.66% | -21.91% | -19.44% | -15.36% |
| Total Depreciation and Amortization | 14.73% | 4.43% | 5.14% | 3.34% | 14.98% |
| Total Amortization of Deferred Charges | -4.23% | -4.81% | -3.58% | -1.73% | 10.67% |
| Total Other Non-Cash Items | -11.39% | 8.49% | -8.39% | 16.93% | 23.50% |
| Change in Net Operating Assets | -38.58% | 80.79% | 91.90% | -30.80% | -250.05% |
| Cash from Operations | -47.10% | -32.75% | -27.53% | -21.66% | -24.25% |
| Capital Expenditure | -45.82% | -87.48% | -64.98% | -9.34% | -21.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -271.82% | -1,824.94% | -166.86% | -267.63% | 310.32% |
| Cash from Investing | -289.41% | -2,750.12% | -160.81% | -247.70% | 282.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -298.24% | -77.54% | -114.46% | 64.81% | 14.74% |
| Issuance of Common Stock | 43.02% | 603.75% | 600.73% | 321.59% | 163.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -713.69% | -206.81% | 100.00% | 100.00% |
| Cash from Financing | 58.78% | 695.41% | 696.15% | 65.49% | 10.26% |
| Foreign Exchange rate Adjustments | 44.97% | 146.08% | -422.80% | 150.33% | 156.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.08% | 48.42% | 112.28% | -135.41% | 222.11% |